These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antibiotic options for treating community-acquired MRSA. Powell JP; Wenzel RP Expert Rev Anti Infect Ther; 2008 Jun; 6(3):299-307. PubMed ID: 18588495 [TBL] [Abstract][Full Text] [Related]
4. Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections. Cohen PR; Grossman ME J Am Acad Dermatol; 2004 Jul; 51(1):132-5. PubMed ID: 15243539 [No Abstract] [Full Text] [Related]
5. Community acquired methicillin-resistant Staphylococcus aureus hand infections: case reports and clinical implications. Karanas YL; Bogdan MA; Chang J J Hand Surg Am; 2000 Jul; 25(4):760-3. PubMed ID: 10913220 [TBL] [Abstract][Full Text] [Related]
6. Epidemiology and treatment of community-associated methicillin-resistant Staphylococcus aureus in children. Marcinak JF; Frank AL Expert Rev Anti Infect Ther; 2006 Feb; 4(1):91-100. PubMed ID: 16441212 [TBL] [Abstract][Full Text] [Related]
7. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization. Terushkin V; Brownell I J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595 [No Abstract] [Full Text] [Related]
8. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Lawrence KR; Golik MV; Davidson L Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720 [TBL] [Abstract][Full Text] [Related]
13. [Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA)--a new challenge in the ambulatory setting?]. Buehlmann M; Chuard C Rev Med Suisse; 2007 Oct; 3(128):2289-90, 2292-3. PubMed ID: 17985605 [TBL] [Abstract][Full Text] [Related]
14. Community-acquired methicillin-resistant Staphylococcus aureus: not just a spider bite. Vozdecky C Fam Community Health; 2009; 32(1):76-84. PubMed ID: 19092436 [TBL] [Abstract][Full Text] [Related]
15. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult. Graue N; Korber A; Schmid EN; Rath PM; Dissemond J J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):766-7. PubMed ID: 18482040 [No Abstract] [Full Text] [Related]
16. Daptomycin: rationale and role in the management of skin and soft tissue infections. Seaton RA J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii15-23. PubMed ID: 18829721 [TBL] [Abstract][Full Text] [Related]
17. [Antibiotic susceptibility of Staphylococcus aureus strains responsible for community-acquired skin infections]. Bernard P; Jarlier V; Santerre-Henriksen A Ann Dermatol Venereol; 2008 Jan; 135(1):13-9. PubMed ID: 18342068 [TBL] [Abstract][Full Text] [Related]
18. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Gorwitz RJ Clin Infect Dis; 2007 Mar; 44(6):785-7. PubMed ID: 17304448 [No Abstract] [Full Text] [Related]